Reinforcing targeted therapeutics with phenotypic stability factors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reinforcing targeted therapeutics with phenotypic stability factors
Authors
Keywords
-
Journal
CELL CYCLE
Volume 13, Issue 24, Pages 3818-3822
Publisher
Informa UK Limited
Online
2014-11-19
DOI
10.4161/15384101.2014.985071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mammary Morphogenesis and Regeneration Require the Inhibition of EMT at Terminal End Buds by Ovol2 Transcriptional Repressor
- (2014) Kazuhide Watanabe et al. DEVELOPMENTAL CELL
- Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation
- (2014) Li Li et al. PLoS One
- Breast cancer stem cells: Obstacles to therapy
- (2012) Matthew Smalley et al. CANCER LETTERS
- The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells
- (2012) Alexey V. Bazarov et al. CELL CYCLE
- Breast Cancer Stem Cells: A Novel Therapeutic Target
- (2012) Sudeshna Gangopadhyay et al. Clinical Breast Cancer
- Cdk4/6 Inhibition Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells
- (2012) F. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways
- (2012) D. Horiuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-canonical Notch signaling: emerging role and mechanism
- (2012) Peter Andersen et al. TRENDS IN CELL BIOLOGY
- Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
- (2011) K Pandya et al. BRITISH JOURNAL OF CANCER
- Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+breast cancer patients
- (2011) Maurizio Scaltriti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibiting NF-κB activation by small molecules as a therapeutic strategy
- (2010) Subash C. Gupta et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-β Switch from a Suppressor to a Promoter of Cancer Cell Proliferation
- (2010) Garima Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Notch Signaling Pathway as a Therapeutic Target in Breast Cancer
- (2010) H. Al-Hussaini et al. MOLECULAR CANCER THERAPEUTICS
- A novel interaction between HER2/neu and cyclin E in breast cancer
- (2010) E A Mittendorf et al. ONCOGENE
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
- (2010) J L Dean et al. ONCOGENE
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- p21 and p27: roles in carcinogenesis and drug resistance
- (2008) Abde M. Abukhdeir et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- G1 arrest and expression of cyclin-dependent kinase inhibitors in tamoxifen-treated MCF-7 human breast cancer cells
- (2008) Akira ICHIKAWA et al. Human Cell
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started